Drug therapy: Solamargine and other solasodine rhamnosyl glycosides as anticancer agents
Open Access
- 1 January 2013
- journal article
- Published by Scientific Research Publishing, Inc. in Modern Chemotherapy
- Vol. 02 (02), 33-49
- https://doi.org/10.4236/mc.2013.22005
Abstract
In the last century, the discovery of cytotoxic agents was revolutionary for anticancer therapy. These therapies have resulted in better understanding of cancer in general. However, the development of agents that combine efficacy, safety and convenience remains a great challenge. The narrow, if not adverse, therapeutic index of most drugs, the damage not only to cancer cells, but also to normal and healthy tissue and the occurrence of resistance have limited anticancer efficacy. This review presents the development of promising novel cytotoxic solasodine rhamnosyl glycoside drugs that offer not only gains in specificity and efficacy, but also in safety, tolerability, non-resistance and convenience in the treatment of patients with cancer.Keywords
This publication has 28 references indexed in Scilit:
- Solasodine Rhamnosyl Glycosides Cause Apoptosis in Cancer Cells. Do They Also Prime the Immune System Resulting in Long-Term Protection against Cancer?Planta Medica, 2012
- Treatment of Bowen's Disease on the Penis with Low Concentration of a Standard Mixture of Solasodine Glycosides and Liquid NitrogenDermatologic Surgery, 2011
- Solamargine induces apoptosis associated with p53 transcription-dependent and transcription-independent pathways in human osteosarcoma U2OS cellsLife Sciences, 2011
- Solamargine upregulation of Fas, downregulation of HER2, and enhancement of cytotoxicity using epirubicin in NSCLC cellsMolecular Nutrition & Food Research, 2007
- Action of solamargine on human lung cancer cells – enhancement of the susceptibility of cancer cells to TNFsFEBS Letters, 2004
- Solamargine Purified fromSolanum incanumChinese Herb Triggers Gene Expression of Human TNFR I Which May Lead to Cell ApoptosisBiochemical and Biophysical Research Communications, 1996
- Topical treatment of malignant and premalignant skin lesions by very low concentrations of a standard mixture (BEC) of solasodine glycosidesCancer Letters, 1991
- Solasodine glycosides. In vitro preferential cytotoxicity for human cancer cellsCancer Letters, 1990
- HPLC of Glycoalkaloids fromSolanum sodomaeumPlanta Medica, 1987
- Antitumour Effects of Glycoalkaloids Isolated fromSolanum sodomaeumPlanta Medica, 1987